Psychiatry and Neurology, Epilepsy · New York, NY
NPI
1861400814
Since 2006
Specialty
Psychiatry and Neurology, Epilepsy
Code 2084E0001X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
223 E 34th St
New York, NY, 10016
Phone (646) 558-0807
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
228 services
Medicare patients, 2024
100
Average age 72
Drug cost, 2024
$232K
1,911 prescriptions
Company payments, 2025
$150
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Siddhartha S Nadkarni was code 95720 (neurologic), 124 times for 69 patients. In total Siddhartha S Nadkarni billed 228 services in 10 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-01-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95720 Neurologic | Facility | 124 | 69 | $188.12 | $23K |
| 99232 Hospital E&M - Subsequent | Facility | 42 | 20 | $71.79 | $3,015 |
| 95718 Neurologic | Facility | 11 | 11 | $122.46 | $1,347 |
| 95816 Neurologic | Facility | 11 | 11 | $51.42 | $566 |
By year: 2022 $37K for 337 services; 2023 $39K for 296 services; 2024 $33K for 228 services.
Medicare prescription drug claims, 2024
In 2024, the drug Siddhartha S Nadkarni prescribed most often to Medicare patients was Venlafaxine Hcl Er (Venlafaxine Hcl), with 126 prescriptions and refills. In total Siddhartha S Nadkarni wrote 1,911 Medicare prescriptions that cost $232K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Venlafaxine Hcl Er Venlafaxine Hcl | 126 | 165 | 15 | $1,804 |
| Clonazepam Generic | 114 | 124 | 20 | $1,209 |
| Quetiapine Fumarate Generic | 104 | 128 | 19 | $1,485 |
| Mirtazapine Generic | 91 | 100 | 13 | $771 |
| Sertraline Hcl Generic | 82 | 107 | Under 11 | $675 |
| Lamotrigine Generic | 71 | 103 | 11 | $724 |
| Trazodone Hcl Generic | 58 | 78 | Under 11 | $288 |
| Buspirone Hcl Generic | 52 | 60 | Under 11 | $768 |
| Bupropion Xl Bupropion Hcl | 47 | 69 | Under 11 | $1,274 |
| Levetiracetam Generic | 42 | 52 | Under 11 | $440 |
| Lacosamide Generic | 36 | 54 | Under 11 | $2,220 |
| Dextroamphetamine-Amphet Er Dextroamphetamine/Amphetamine | 35 | 35 | Under 11 | $923 |
| Escitalopram Oxalate Generic | 34 | 42 | Under 11 | $424 |
| Propranolol Hcl Er Propranolol Hcl | 34 | 48 | Under 11 | $2,347 |
| Memantine Hcl Generic | 34 | 42 | Under 11 | $1,473 |
Brand drugs: 190 claims; generic drugs: 1,705 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Siddhartha S Nadkarni $150 ($150 in general payments such as food, travel and fees) from 1 company. The largest payer was Axsome Therapeutics, Inc. with $150.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 1 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.